Related Experiment Video
Updated: Apr 29, 2026
10:48
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
9.1K
Is current technology improving outcomes with radiation therapy for gliomas?
Michael Brada1, Brian Haylock1
1From the University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Liverpool; Department of Radiation Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Bebbington, Wirral.
Summary
Modern radiotherapy (RT) techniques improve precision for glioma treatment but haven't increased survival. Future gains focus on reducing treatment toxicity and enhancing patient quality of life through better normal tissue sparing.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Background:
- Radiotherapy (RT) is central to glioma treatment, with three-dimensional conformal RT (3DCRT) as the standard.
- Advances in imaging and RT technology allow for more precise targeting and normal tissue sparing.
Purpose of the Study:
- To evaluate the impact of advanced RT technologies on glioma treatment outcomes.
- To explore the potential of novel RT techniques for improving patient quality of life.
Main Methods:
- Review of advancements in RT delivery, including intensity-modulated RT (IMRT), arcing IMRT, high-precision conformal RT, and proton therapy.
- Analysis of clinical outcomes and toxicity profiles associated with these technologies and altered fractionation regimens.
Main Results:
- Advanced RT techniques improve dose distribution and normal tissue sparing but have not led to improved survival in glioma patients.
- Intensified fractionation regimens have also failed to demonstrate survival benefits.
Conclusions:
- The primary benefit of modern RT technology for gliomas lies in reducing treatment-related toxicity, not necessarily improving overall survival.
- Further research into optimal normal tissue avoidance strategies is crucial for enhancing patient quality of life.
